Deciphera Pharmaceuticals, Inc. (DCPH) has a consensus analyst rating of Buy, based on 26 analysts covering the stock. Of those, 13 recommend buying, 12 recommend holding, and 1 recommend selling.
The analyst consensus price target for DCPH is $26.32, representing a +2.9% upside from the current price of $25.59. Price targets range from a low of $25.00 to a high of $30.00.
